Goldman Sachs analyst expects positive updates from Vertex's first Investor Day as a public company on March 19, reiterates ...
Nvidia (NVDA) CEO Jensen Huang took to the stage Tuesday afternoon to deliver his keynote speech at the chip giant's 2025 GTC event (GPU Technology Conference), where he previewed the company's ...
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...
After hours: March 21 at 7:13:50 PM EDT Loading Chart for VRTX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback